Schneyer Mark C.: insider trades.
Schneyer Mark C. reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($587K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Schneyer Mark C.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | Officer · EVP, CHIEF FINANCIAL OFFICER | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Acadia Pharmaceuticals Inc | S | 5,000 | $29 | 77,120 | Form 4 |
| 2026-08-06 | Acadia Pharmaceuticals Inc | S | 9,292 | $29.34 | 67,828 | Form 4 |
| 2026-08-06 | Acadia Pharmaceuticals Inc | M | 14,292 | $17.84 | 82,120 | Form 4 |
| 2026-08-05 | Acadia Pharmaceuticals Inc | M | 5,849 | $17.84 | 73,677 | Form 4 |
| 2026-08-05 | Acadia Pharmaceuticals Inc | S | 5,849 | $29 | 67,828 | Form 4 |
Questions
What stock did Schneyer Mark C. buy or sell?
Schneyer Mark C. reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($587K), across 1 company.
Is Schneyer Mark C. the same person as other filers with this name?
This page covers SEC CIK 1899977 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schneyer-mark-c-1899977.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.